Exocrine Pancreatic Insufficiency
Also known as: Exocrine Pancreatic Insufficiency (EPI) / Pancreatic exocrine insufficiency / Exocrine pancreatic insufficiency (disorder) / Pancreatic failure / Pancreatic insufficiency (disorder) / Pancreatic insufficiency / Insufficiency pancreatic
Drug | Drug Name | Drug Description |
---|---|---|
DB00085 | Pancrelipase | A purified form of porcine pancreatic lipase, amylase, and protease enzymes used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis. |
DB11065 | Pancrelipase amylase | A lipase used to treat pancreatic exocrine insufficiency. |
DB13147 | Pancrelipase lipase | A lipase used to treat pancreatic exocrine insufficiency. |
DB11066 | Pancrelipase protease | A lipase used to treat pancreatic exocrine insufficiency. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00085 | Pancrelipase | Dietary fat | target |
DB00085 | Pancrelipase | Dietary protein | target |
DB00085 | Pancrelipase | Dietary starch | target |
DB11065 | Pancrelipase amylase | Dietary starch | target |
DB13147 | Pancrelipase lipase | Dietary fat | target |
DB11066 | Pancrelipase protease | Dietary protein | target |